Peripheral Arterial Disease Trial, Recruiting (NCT03987633)

Peripheral Arterial Disease Trial, Recruiting NCT03987633 Sponsor: Future Genetics Limited Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT03987633 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You or a close family member has been diagnosed with the condition being studied in this trial.
You are an NHS patient at one of the participating clinics or hospitals, even if you do not have the condition being studied (you may be asked to take part as a comparison participant).
You are willing to donate a saliva sample, and optionally a blood sample or other biological sample if possible.
You agree to allow researchers to access your medical records.
You are willing to fill in questionnaires about your condition, quality of life, and the study.

Who may not be able to join:

You are not willing or able to give valid consent to take part in the trial.
You are not registered with the NHS for your healthcare.
You lack the mental capacity to consent for yourself and you do not have the condition being specifically studied in this trial.
You lack the mental capacity to consent for yourself and a personal consultee (someone acting on your behalf) has not agreed for you to take part, in line with the Mental Capacity Act 2005 (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dr Mohammed Kamran, Future Genetics Limited

Phone: 00441216673007

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03987633

Sponsor: Future Genetics Limited

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: 00441216673007

More information: https://clinicaltrials.gov/study/NCT03987633

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You or a close family member has been diagnosed with the condition being studied in this trial.
You are an NHS patient at one of the participating clinics or hospitals, even if you do not have the condition being studied (you may be asked to take part as a comparison participant).
You are willing to donate a saliva sample, and optionally a blood sample or other biological sample if possible.
You agree to allow researchers to access your medical records.
You are willing to fill in questionnaires about your condition, quality of life, and the study.

Who may not be able to join:

You are not willing or able to give valid consent to take part in the trial.
You are not registered with the NHS for your healthcare.
You lack the mental capacity to consent for yourself and you do not have the condition being specifically studied in this trial.
You lack the mental capacity to consent for yourself and a personal consultee (someone acting on your behalf) has not agreed for you to take part, in line with the Mental Capacity Act 2005 (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Future Genetics Limited

Registry

ClinicalTrials.gov

Start date

1 February 2020

Est. completion

1 February 2028

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Ethnic disparities in treatment failure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov